Clinical Trials · NCT06057077
Semaglutide GLP1 Agonists With Degludec Basal-bolus Insulin in Early Type 1 Diabetes to Basal-bolus
- Phase
- Phase 1/Phase 2
- Recruitment status
- Unknown
- Sponsor
- Ministry of Health, Saudi Arabia
- Enrollment
- 120
- Start date
- Jan 2024
- Locations
- See registry
- Primary endpoint
- change in HA1c and mounts of insulin of basal and bolus which will be taken daily is the same or decreased after one year of follow up